Preparation, in vitro and in vivo evaluation of bexarotene nanocrystals with surface modification by folate-chitosan conjugates

References

• Aoki N, Nishikawa M, Hattori K. (2003). Synthesis of chitosan derivatives bearing cyclodextrin and adsorption of p-nonylphenol and bisphenol A. Carbohydr Polym 52:219–23
   Web of Science ®Google Scholar
• Chen LJ, Wang YJ, Zhang JZ, et al. (2013). Bexarotene nanocrystal – oral and parenteral formulation development, characterization and pharmacokinetic evaluation. Eur J Pharm Biopharm; in press
   Web of Science ®Google Scholar
• Gao L, Liu G, Ma JL, et al. (2012). Drug nanocrystals: in vivo performances. J Control Release 160:418–30
   PubMed Web of Science ®Google Scholar
• Guo JJ, Yue PF, Lv JL, et al. (2013). Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension. Int J Pharm 441:227–33
   PubMed Web of Science ®Google Scholar
• Hao LL, Wang XY, Zhang DR, et al. (2012). Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals. Int J Pharm 433:157–64
   PubMed Web of Science ®Google Scholar
• Hermann TW, Yen WC, Tooker P, et al. (2005). The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells. Lung Cancer 50:9–18
   PubMed Web of Science ®Google Scholar
• Ji JG, Wu DJ, Liu L, et al. (2011). Preparation, characterization, and in vitro release of folic acid-conjugated chitosan nanoparticles loaded with methotrexate for targeted delivery. Polym Bull 68:1707–20
   Web of Science ®Google Scholar
• Kakran M, Shegokar R, Sahoo NG, et al. (2012). Fabrication of quercetin nanocrystals: comparison of different methods. Eur J Pharm Biopharm 80:113–21
   PubMed Web of Science ®Google Scholar
• Kocbek P, Baumgartner S, Kristl J. (2006). Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm 312:179–86
   PubMed Web of Science ®Google Scholar
• Li PW, Wang YC, Zeng FB, et al. (2011). Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells. Carbohydr Res 346:801–6
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang Y, Hill J, et al. (2008). The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice. Br J Cancer 98:1380–8
   PubMed Web of Science ®Google Scholar
• Lu YJ, Low PS. (2012). Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 64:342–52
   Web of Science ®Google Scholar
• Malik SM, Collins B, Pishvaian M, et al. (2011). A phase I trial of bexarotene in combination with docetaxel in patients with advanced solid tumors. Clin Lung Cancer 12:231–6
   PubMed Web of Science ®Google Scholar
• Mansouri S, Cuie Y, Winnik F, et al. (2006). Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials 27:2060–5
   PubMed Web of Science ®Google Scholar
• Mehta N, Wayne AS, Kim YH, et al. (2012). Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations. Clin Lymphoma Myeloma Leukemia 12:20–5
   PubMed Web of Science ®Google Scholar
• Morris VB, Sharma CP. (2010). Folate mediated in vitro targeting of depolymerised trimethylated chitosan having arginine functionality. J Colloid Interface Sci 348:360–8
   PubMed Web of Science ®Google Scholar
• Pardeike J, Müller RH. (2010). Nanosuspensions: a promising formulation for the new phospholipase A2 inhibitor PX-18. Int J Pharm 391:322–9
   PubMed Web of Science ®Google Scholar
• Pardeike J, Strohmeier DM, Schrödl N, et al. (2011). Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines. Int J Pharm 420:93–100
   PubMed Web of Science ®Google Scholar
• Paulos CM, Turk MJ, Breur GJ, Low PS. (2004). Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev 56:1205–17
   PubMed Web of Science ®Google Scholar
• Quan P, Shi K, Piao HZ, et al. (2012). A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability. Int J Pharm 430:366–71
   PubMed Web of Science ®Google Scholar
• Sun B, Yeo Y. (2012). Nanocrystals for the parenteral delivery of poorly water-soluble drugs. Curr Opin Solid State Mater Sci 16:295–301
   PubMed Web of Science ®Google Scholar
• Sun W, Tian W, Zhang YY, et al. (2012). Effect of novel stabilizers – cationic polymers on the particle size and physical stability of poorly soluble drug nanocrystals. Nanomed Nanotechnol Biol Med 8:460–7
   PubMed Web of Science ®Google Scholar
• Wan AJ, Sun Y, Li HL. (2008). Characterization of folate-graft-chitosan as a scaffold for nitric oxide release. Int J Biol Macromol 43:415–21
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang J, Watanabe W. (2011). Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev 63:456–69
   PubMed Web of Science ®Google Scholar
• Yen WC. (2004). A selective retinoid X receptor agonist bexarotene (targretin) prevents and overcomes acquired paclitaxel (taxol) resistance in human non-small cell lung cancer. Clin Cancer Res 10:8656–64
   PubMed Web of Science ®Google Scholar
• Zhang H, Hollis CP, Zhang Q, Li TL. (2011). Preparation and antitumor study of camptothecin nanocrystals. Int J Pharm 415:293–300
   PubMed Web of Science ®Google Scholar
• Zhang Q, Pan J, Zhang J, et al. (2010). Aerosolized bexarotene inhibits lung tumorigenesis without increasing plasma triglyceride and cholesterol levels in mice. Cancer Prevent Res 4:270–6
   PubMed Web of Science ®Google Scholar
• Zhang ZP, Lee SH, Feng SS. (2007). Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials 28:1889–99
   PubMed Web of Science ®Google Scholar
• Zhu HY, Liu F, Guo J, et al. (2011). Folate-modified chitosan micelles with enhanced tumor targeting evaluated by near infrared imaging system. Carbohydr Polym 86:1118–29
   Web of Science ®Google Scholar